From: Synergistic anti-malarial action of cryptolepine and artemisinins
Parameters | Control | Cryptolepine | ||
---|---|---|---|---|
25 mg kg−1 | 50 mg kg−1 | 100 mg kg−1 | ||
WBC (×103/µL) | 9.83 ± 1.63 | 8.37 ± 1.54 | 13.03 ± 2.28 | 12.73 ± 1.04 |
RBC (×106/µL) | 6.41 ± 0.45 | 6.86 ± 0.26 | 6.58 ± 0.24 | 6.47 ± 0.29 |
HGB (g/dL) | 11.63 ± 0.93 | 12.07 ± 0.20 | 11.77 ± 0.23 | 11.93 ± 0.12 |
HCT (%) | 39.27 ± 1.68 | 38.4 ± 1.07 | 37.3 ± 0.90 | 35.3 ± 1.15 |
MCV (fL) | 61.7 ± 2.19 | 56.03 ± 0.63 | 56.77 ± 0.72 | 54.63 ± 0.68* |
MCH (pg) | 18.13 ± 0.69 | 17.67 ± 0.44 | 17.9 ± 0.37 | 18.53 ± 0.69 |
MCHC (g/dL) | 29.43 ± 1.15 | 31.47 ± 0.44 | 31.57 ± 0.45 | 33.87 ± 0.83* |
PLT (×103/µL) | 516.33 ± 76.50 | 821.33 ± 9.02 | 725.67 ± 67.65 | 843.67 ± 44.67 |
LYMP (%) | 72 ± 4.18 | 75.73 ± 2.80 | 77.38 ± 1.73 | 83.43 ± 2.84 |